Correlation Between American Balanced and Biotechnology Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both American Balanced and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining American Balanced and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between American Balanced Fund and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on American Balanced and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in American Balanced with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of American Balanced and Biotechnology Ultrasector.

Diversification Opportunities for American Balanced and Biotechnology Ultrasector

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between American and Biotechnology is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding American Balanced Fund and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and American Balanced is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on American Balanced Fund are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of American Balanced i.e., American Balanced and Biotechnology Ultrasector go up and down completely randomly.

Pair Corralation between American Balanced and Biotechnology Ultrasector

Assuming the 90 days horizon American Balanced is expected to generate 1.36 times less return on investment than Biotechnology Ultrasector. But when comparing it to its historical volatility, American Balanced Fund is 3.95 times less risky than Biotechnology Ultrasector. It trades about 0.12 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  5,988  in Biotechnology Ultrasector Profund on August 26, 2024 and sell it today you would earn a total of  524.00  from holding Biotechnology Ultrasector Profund or generate 8.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

American Balanced Fund  vs.  Biotechnology Ultrasector Prof

 Performance 
       Timeline  
American Balanced 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in American Balanced Fund are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, American Balanced is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Biotechnology Ultrasector 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

American Balanced and Biotechnology Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with American Balanced and Biotechnology Ultrasector

The main advantage of trading using opposite American Balanced and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if American Balanced position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.
The idea behind American Balanced Fund and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Transaction History
View history of all your transactions and understand their impact on performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital